Discover open access scientific publications

Search, annotate, share and cite publications

Publications by JanWillem H. P. Lardenoye

Adenoviral Expression of a Urokinase Receptor-Targeted Protease Inhibitor Inhibits Neointima Formation in Murine and Human Blood Vessels

Circulation

Cardiovascular Medicine

Physiology

Cardiology

2001

English

Related publications

Intracellular Expression of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Variants Inhibits Replication of Wild-Type and Protease Inhibitor-Resistant HIV-1 Strains in Human T-Cell Lines.

English

Berberine Inhibits HIV Protease Inhibitor-Induced Inflammatory Response by Modulating ER Stress Signaling Pathways in Murine Macrophages

PLoS ONE

Multidisciplinary

2010

English

A Chimeric Platelet-Targeted Urokinase Prodrug Selectively Blocks New Thrombus Formation

Journal of Clinical Investigation

Medicine

2015

English

Increased Expression of Estrogen Receptor- mRNA in Male Blood Vessels After Vascular Injury

Circulation Research

Cardiovascular Medicine

Physiology

Cardiology

1998

English

The Receptor for Urokinase Type Plasminogen Activator Polarizes Expression of the Protease to the Leading Edge of Migrating Monocytes and Promotes Degradation of Enzyme Inhibitor Complexes

Journal of Cell Biology

Medicine

Cell Biology

1990

English

Human Protease-Activated Receptor 1 Expression in Malignant Epithelia: A Role in Invasiveness

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

Cardiology

2003

English

RNAi-mediated Downregulation of Urokinase Plasminogen Activator and Its Receptor in Human Meningioma Cells Inhibits Tumor Invasion and Growth

International Journal of Oncology

Cancer Research

Oncology

2006

English

A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells

Journal of Pharmacology and Experimental Therapeutics

Molecular Medicine

Pharmacology

2017

English

A Urokinase-Sensitive Region of the Human Urokinase Receptor Is Responsible for Its Chemotactic Activity

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by JanWillem H. P. Lardenoye

Adenoviral Expression of a Urokinase Receptor-Targeted Protease Inhibitor Inhibits Neointima Formation in Murine and Human Blood Vessels

Related publications

Intracellular Expression of Human Immunodeficiency Virus Type 1 (HIV-1) Protease Variants Inhibits Replication of Wild-Type and Protease Inhibitor-Resistant HIV-1 Strains in Human T-Cell Lines.

Berberine Inhibits HIV Protease Inhibitor-Induced Inflammatory Response by Modulating ER Stress Signaling Pathways in Murine Macrophages

A Chimeric Platelet-Targeted Urokinase Prodrug Selectively Blocks New Thrombus Formation

Increased Expression of Estrogen Receptor- mRNA in Male Blood Vessels After Vascular Injury

The Receptor for Urokinase Type Plasminogen Activator Polarizes Expression of the Protease to the Leading Edge of Migrating Monocytes and Promotes Degradation of Enzyme Inhibitor Complexes

Human Protease-Activated Receptor 1 Expression in Malignant Epithelia: A Role in Invasiveness

RNAi-mediated Downregulation of Urokinase Plasminogen Activator and Its Receptor in Human Meningioma Cells Inhibits Tumor Invasion and Growth

A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells

A Urokinase-Sensitive Region of the Human Urokinase Receptor Is Responsible for Its Chemotactic Activity